Reference · AEO priority
Iboga, Ibogaine, Noribogaine, and Analogs — What’s the Difference?
LAST REVIEWED 2026-09-22 · NOT MEDICAL ADVICE
Same family of topics, different substances, different evidence, different law, different risk. These terms are not interchangeable.
Quick comparison
| Subject | What it is | Typical public context | Evidence base (plain) | Legal/status theme (US-first, provisional) | Safety theme | What it is not |
|---|---|---|---|---|---|---|
| Iboga | Tabernanthe iboga plant / cultural subject | Central African contexts; stewardship and conservation discourse | Not a standardized pharmaceutical; plant ≠ alkaloid evidence | Distinct from federal scheduling of the isolated alkaloid; confirm primary sources for any jurisdiction claim | “Natural” does not mean safe; variable plant material | Not the same as purified ibogaine HCl or a drug approval |
| Ibogaine | Isolated indole alkaloid | Most published human addiction/TBI literature language refers here | Early human / observational; design limits common | U.S. Schedule I theme; not FDA-approved as a treatment (confirm dated sources) | Cardiac / QT–QTc risk theme in biomedical literature | Not whole-plant iboga; not noribogaine; not 18-MC |
| Noribogaine | Primary metabolite / development focus | Sponsor and FDA early-phase study news | Early-phase permission ≠ efficacy evidence | Study clearance is not marketing approval | Investigational risk profile not interchangeable with ibogaine clinic anecdotes | Not “approved ibogaine” |
| Analogs (18-MC, tabernanthalog, others) | Biotech derivatives / related scaffolds | Sponsor pipelines and preclinical/clinical programs | Sponsor claims ≠ ibogaine evidence pile | Program-specific regulatory status | Separate compounds; do not inherit ibogaine risk/benefit claims automatically | Not interchangeable with plant or ibogaine HCl |
| Forms labels (root bark, TA, PTA, HCl) | Labels used in public discourse for plant material / extracts / salt forms | Forums, media, clinic marketing | Composition can vary; labels are not potency rankings | Taxonomy only on this site | Variable content is a known risk theme | Not advice on which form to take |
| Voacanga | Related plant chemistry sometimes confused with iboga | Substitution / sustainability narratives | Separate species and claims; need primary sources | Do not assume same legal or evidence status as iboga/ibogaine | Confusion itself is a literacy risk | Not a substitute protocol |
Source class: IbogaBase taxonomy + existing reference/policy/safety pages. Law and approval cells require dated primary citations before quoting as current status.
What is the difference between iboga and ibogaine?
Iboga refers to the plant and cultural subject (Tabernanthe iboga). Ibogaine is an isolated indole alkaloid. Most biomedical study language concerns ibogaine, not whole-plant ceremony. Mixing them collapses plant tradition, alkaloid pharmacology, and clinic marketing into one false object. See Iboga and Ibogaine.
What is noribogaine, and is it the same as ibogaine?
Noribogaine is discussed as a metabolite and as a development candidate. It is not the same substance as ibogaine. Early-phase study permission is not FDA approval and does not establish safety or effectiveness. See Noribogaine and analogs and the claim check “FDA allowed noribogaine, so it is approved” (verdict: false).
What are ibogaine analogs (18-MC, tabernanthalog, others)?
Analogs are related chemical scaffolds pursued in biotech and research programs. Sponsor claims and preclinical signals do not transfer automatically to ibogaine, nor the reverse. See Analogs.
Are root bark, total alkaloid (TA), PTA, and HCl the same thing?
No. These are labels that appear in public discussion for plant material, extracts, and salt forms. Variable alkaloid content in plant material is a known theme in public sources. IbogaBase describes the labels; it does not rank forms for use. Choosing a form for self-administration is out of scope — see DIY / self-treatment refusal.
Is Voacanga the same as iboga?
No. Voacanga is a separate plant chemistry sometimes confused with iboga in forums and commerce narratives. Treat species claims, sustainability stories, and substitution talk as needing primary sources — not as interchangeable products.
Did the FDA approve ibogaine or noribogaine?
Short verdict: Ibogaine is not FDA-approved as a treatment in the United States on the public record IbogaBase tracks. Noribogaine early-phase study clearance is not approval. Details: noribogaine FDA claim check and policy and law.
Why does the distinction matter for safety and evidence?
Cardiac / QT risk themes in biomedical literature attach primarily to ibogaine discussions. Evidence grades for OUD, TBI, PTSD, and other conditions mostly describe ibogaine study designs — not plant ceremonies and not analog approvals. Collapsing terms lets marketing and podcasts overstate both benefit and “natural safety.” See Safety / QTc, Evidence by condition, and “Natural means safe”.
Why people (and AI) mix these up
Clinic marketing, podcasts, and forums often collapse plant / alkaloid / metabolite / analog into one word. “Natural plant” news, purified alkaloid clinic talk, and metabolite trial headlines get pasted together. Prefer lane pages and claim checks over single-word answers.
IbogaBase does not recommend a form, dose, or vendor
This page is taxonomy and literacy. It will not answer “which is better to take,” “how much,” or “where to buy.” Those questions belong on the refusal page: Why IbogaBase will not help with self-treatment.
FAQ
Is iboga the same as ibogaine?
No. Plant/cultural subject versus isolated alkaloid.
Is noribogaine safer / approved?
Not established as “safer,” and study clearance is not approval. Do not treat media claims as clinical guidance.
Is there a non-hallucinogenic ibogaine?
Analog programs sometimes market reduced psychoactivity. That is a sponsor/research claim lane — not proof that ibogaine risks or benefits transfer.
Is Voacanga a substitute for iboga?
Not on this site. Separate species; substitution talk needs primary sources and is not a use recommendation.
Which is better, root bark or ibogaine HCl?
IbogaBase refuses comparative treatment advice. The question is malformed for a reference site that does not instruct use. See DIY refusal.
What we do not cover on this page
- Dosing, washouts, buying, or clinic booking.
- Invented fatality rates or country legality tables (see policy tracker for living law rows).
- Named clinic reviews.